Literature DB >> 8536271

Tumor cells engineered to produce cytokines or cofactors as cellular vaccines: do animal studies really support clinical trials?

M P Colombo1, M Rodolfo.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 8536271     DOI： 10.1007/bf01517213

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN： 0340-7004            Impact factor:   6.968


× No keyword cloud information.
  38 in total

1.  Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.

Authors:  R Gavioli; P O De Campos-Lima; M G Kurilla; E Kieff; G Klein; M G Masucci
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

2.  A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P G Coulie; F Lehmann; B Lethé; J Herman; C Lurquin; M Andrawiss; T Boon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

3.  An intracisternal A-particle sequence codes for an antigen recognized by syngeneic cytolytic T lymphocytes on a mouse spontaneous leukemia.

Authors:  V de Bergeyck; E De Plaen; P Chomez; T Boon; A Van Pel
Journal:  Eur J Immunol       Date:  1994-09       Impact factor: 5.532

4.  Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene.

Authors:  L Cordier; M T Duffour; J C Sabourin; M G Lee; J Cabannes; T Ragot; M Perricaudet; H Haddada
Journal:  Gene Ther       Date:  1995-01       Impact factor: 5.250

Review 5.  Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells.

Authors:  P D Greenberg
Journal:  Adv Immunol       Date:  1991       Impact factor: 3.543

6.  Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy.

Authors:  C D Estin; U S Stevenson; G D Plowman; S L Hu; P Sridhar; I Hellström; J P Brown; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

Review 7.  Tumor antigens recognized by T lymphocytes.

Authors:  T Boon; J C Cerottini; B Van den Eynde; P van der Bruggen; A Van Pel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

8.  Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.

Authors:  M Kovacsovics-Bankowski; K Clark; B Benacerraf; K L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

9.  Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.

Authors:  M J Bevan
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

10.  A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

Authors:  P G Coulie; V Brichard; A Van Pel; T Wölfel; J Schneider; C Traversari; S Mattei; E De Plaen; C Lurquin; J P Szikora; J C Renauld; T Boon
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307
View more
  3 in total

1.  Antimetastatic vaccination against Lewis lung carcinoma with autologous tumor cells modified to express murine interleukin 12.

Authors:  D Popovic; K M El-Shami; E Vadai; M Feldman; E Tzehoval; L Eisenbach
Journal:  Clin Exp Metastasis       Date:  1998-10       Impact factor: 5.150

2.  Antitumor immunity induced by irradiated tumor cells producing macrophage colony-stimulating factor.

Authors:  S Suzu; F Kimura; M Tanaka-Douzono; M Yamada; Y Nakamura; N Wakimoto; K Sato; T Morita; K Ikeda; K Motoyoshi
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

3.  Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model.

Authors:  Eonju Oh; Il-Kyu Choi; JinWoo Hong; Chae-Ok Yun
Journal:  Oncotarget       Date:  2017-01-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.